Works matching IS 02704137 AND DT 2022 AND VI 82 AND IP 16

Results: 10

CD47 (don't eat me signal) expression levels and its relationship with clinicopathologic features in early‐stage prostate carcinoma.

Published in:

Prostate, 2022, v. 82, n. 16, p. 1564, doi. 10.1002/pros.24432

By:

Semiz, Hüseyin S.;
Küçük, Ülkü;
Kısa, Erdem;
Keskinkılıç, Merve;
Süyün, Dilara Ecem;
Arayıcı, Mehmet Emin;
Atağ, Elif;
Karaoglu, Aziz

Publication type:

Article

Are higher pre‐diagnosis follicle stimulating hormone levels associated with long‐term prostate cancer risk?

Published in:

Prostate, 2022, v. 82, n. 16, p. 1558, doi. 10.1002/pros.24429

By:

Dymanus, Kyle;
Howard, Lauren E.;
Oyekunle, Taofik;
De Hoedt, Amanda M.;
Labadzhyan, Artak;
Polascik, Thomas;
Freedland, Stephen J.;
Klaassen, Zachary

Publication type:

Article

Prostate cancer cells demonstrate unique metabolism and substrate adaptability acutely after androgen deprivation therapy.

Published in:

Prostate, 2022, v. 82, n. 16, p. 1547, doi. 10.1002/pros.24428

By:

Filon, Mikolaj J.;
Gillette, Amani A.;
Yang, Bing;
Khemees, Tariq A.;
Skala, Melissa C.;
Jarrard, David F.

Publication type:

Article

Circulating microRNA profiling for prediction of oncological outcomes in prostate cancer patients following radical prostatectomy.

Published in:

Prostate, 2022, v. 82, n. 16, p. 1537, doi. 10.1002/pros.24427

By:

Takamori, Hajime;
Urabe, Fumihiko;
Matsuzaki, Juntaro;
Kimura, Shoji;
Sasaki, Hiroshi;
Kimura, Takahiro;
Inaba, Koji;
Nakamura, Eijiro;
Matsui, Yoshiyuki;
Fujimoto, Hiroyuki;
Ochiya, Takahiro

Publication type:

Article

PSA provocation by bipolar androgen therapy may predict duration of response to first‐line androgen deprivation: Updated results from the BATMAN study.

Published in:

Prostate, 2022, v. 82, n. 16, p. 1529, doi. 10.1002/pros.24426

By:

Denmeade, Samuel;
Lim, Su J.;
Isaaccson Velho, Pedro;
Wang, Hao

Publication type:

Article

Prostate cancer grade downgrading at time of prostatectomy provides risk‐stratification insight into future tumor behavior after prostatectomy.

Published in:

Prostate, 2022, v. 82, n. 16, p. 1520, doi. 10.1002/pros.24425

By:

Wang, Shu;
Ryan Russell, J.;
Drescher, Max;
Park, Ashley;
Legesse, Teklu;
Kundra, Vikas;
Tran, Phuoc T.;
Phelan, Michael;
Naslund, Michael;
Minhaj Siddiqui, M.

Publication type:

Article

Localization of macrophage subtypes and neutrophils in the prostate tumor microenvironment and their association with prostate cancer racial disparities.

Published in:

Prostate, 2022, v. 82, n. 16, p. 1505, doi. 10.1002/pros.24424

By:

Maynard, Janielle P.;
Godwin, Taylor N.;
Lu, Jiayun;
Vidal, Igor;
Lotan, Tamara L.;
De Marzo, Angelo M.;
Joshu, Corinne E.;
Sfanos, Karen S.

Publication type:

Article

Differential effects of omega‐3 PUFAS on tumor progression at early and advanced stages in TRAMP mice.

Published in:

Prostate, 2022, v. 82, n. 16, p. 1491, doi. 10.1002/pros.24421

By:

Amaro, Gustavo M.;
da Silva, Alana D. T.;
Tamarindo, Guilherme H.;
Lamas, Celina de A.;
Taboga, Sebastião R.;
Cagnon, Valéria Helena Alves;
Góes, Rejane M.

Publication type:

Article

Radiographic paradoxical response in metastatic castrate‐resistant prostate cancer (mCRPC) managed with new generation anti‐androgens: a retrospective analysis.

Published in:

Prostate, 2022, v. 82, n. 16, p. 1483, doi. 10.1002/pros.24413

By:

Alamiri, Jamal;
Britton, Cameron J.;
Ahmed, Mohamed E.;
Andrews, Jack R.;
Higa, Julianna L.;
Dundar, Ayca;
Karnes, R. Jeffrey;
Kwon, Eugene;
Lowe, Val J.;
Kendi, Ayse T.;
Bold, Michael S.;
Pagliaro, Lance C.

Publication type:

Article

Issue Information.

Published in:: Prostate, 2022, v. 82, n. 16, p. 1481, doi. 10.1002/pros.24166
Publication type:: Article